Conditions: Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 503
Healthy volunteers: no

Brief summary:
To investigate efficacy, safety and tolerability of BI 1356 versus placebo

Detailed description:

Arms:
arm 1: linagliptin 5 mg once daily arm 2: placebo matching linagliptin 5 mg tablets

Interventions: intervention 1: linagliptin intervention 2: placebo
Intervention descriptions: intervention 1: active intervention 2: placebo

Protocol document: